Skip to main content
Figure 2 | Respiratory Research

Figure 2

From: Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium

Figure 2

24-h profile of least squares means of FEV 1 on Day 1 (A) and 14 (B) (mITT population). A) Data are LSM ± SE. p < 0.001 for indacaterol (150 and 300 μg) vs placebo at each timepoint, p < 0.001 for indacaterol, 150 μg vs tiotropium at 5 and 15 min, p < 0.05 for indacaterol 300 μg vs tiotropium, p < 0.05 for tiotropium vs placebo at each timepoint. B) Data are LSM ± SE. p < 0.001 for indacaterol (150 and 300 μg) and tiotropium vs placebo at each timepoint, p < 0.05 for indacaterol 150 μg vs tiotropium at -50 to 30 min, 12 h and 23 h 10 min, p < 0.05 for indacaterol 300 μg vs tiotropium at 5 min

Back to article page